Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

December 30, 2010

Challenges for Corporate CEOs in 2011

2010 was a trying year for every business. Even with the recent glimmers of economic improvement, 2011 will be no less challenging. I was recently…

Posted by Peter J. Boni

December 21, 2010

Clarient and Avid Radiopharmaceuticals Complete Acquisitions

Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…

Posted by Peter J. Boni

December 10, 2010

Capital Available

In this morning’s Wall Street Journal, Justin Lahart wrote an article titled “Companies Cling to Cash.” Justin reports that there is an increasing number of…

Posted by Stephen T. Zarrilli

November 10, 2010

NFTE Philadelphia Visionary Gala 2010: Honoring Those Who Give Back

A few months ago, I wrote about a partnership that means a great deal to me and to my colleagues at Safeguard Scientifics — the…

Posted by Peter J. Boni

November 8, 2010

Eli Lilly Agrees to Acquire Safeguard Scientifics Partner Company Avid Radiopharmaceuticals

For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…

Posted by Peter J. Boni

November 3, 2010

Aggregate Partner Company Revenue up 73% in Q3; Guidance Increased to between $360 Million to $385 Million

Earlier today in our third quarter results conference call, we announced that our aggregate partner company revenue increased 73 percent in Q3, and that for…

Posted by John E. Shave III

November 2, 2010

Reminder: Safeguard Scientifics Quarterly Results Call Tomorrow Morning

REMINDER: Our third quarter results will be issued tomorrow morning at 6am EDT. Our webcast and conference call will be held at 9am EDT. Here’s…

Posted by John E. Shave III

November 1, 2010

NuPathe Submits Zelrix NDA for the Treatment of Migraine

Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,…

Posted by James A. Datin

October 22, 2010

Partner Company Clarient (Nasdaq: CLRT) to be Acquired by GE Healthcare for $587 Million

At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…

Posted by Peter J. Boni

Content